{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:39:39Z","timestamp":1781800779456,"version":"3.54.5"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T00:00:00Z","timestamp":1369612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 is a recently deorphaned lipid receptor that is activated by the endogenous lipid <jats:italic><jats:styled-content style=\"fixed-case\">N<\/jats:styled-content><\/jats:italic>\u2010arachidonoyl glycine (<jats:styled-content style=\"fixed-case\">NAG<\/jats:styled-content>ly) as well the behaviourally inactive atypical cannabinoid, abnormal cannabidiol (<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>bn\u2010<jats:styled-content style=\"fixed-case\">CBD<\/jats:styled-content>). The presence and\/or function of any <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18\u2010based ocular signalling system remain essentially unstudied. The objectives of this research are: (i) to determine the disposition of <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 receptors and ligands in anterior murine eye, (ii) examine the effect of <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 activation on intraocular pressure (<jats:styled-content style=\"fixed-case\">IOP<\/jats:styled-content>) in a murine model, including knockout mice for <jats:styled-content style=\"fixed-case\">CB<jats:sub>1<\/jats:sub><\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">CB<jats:sub>2<\/jats:sub><\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>55.<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">IOP<\/jats:styled-content> was measured in mice following topical application of <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>bn\u2010<jats:styled-content style=\"fixed-case\">CBD<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">NAG<\/jats:styled-content>ly or the <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>55\/<jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 agonist <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>\u20101602, alone or with injection of the <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 antagonist, <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>\u20101918. <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 protein localization was assessed with immunohistochemistry. Endocannabinoids were measured using <jats:styled-content style=\"fixed-case\">LC<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">MS\u2010MS<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 protein was expressed most prominently in the ciliary epithelium and the corneal epithelium and, interestingly, in the trabecular meshwork. The <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 ligand, <jats:styled-content style=\"fixed-case\">NAG<\/jats:styled-content>ly, was also detected in mouse eye at a level comparable to that seen in the brain. Abn\u2010<jats:styled-content style=\"fixed-case\">CBD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">NAG<\/jats:styled-content>ly, but not <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>\u20101602, significantly reduced <jats:styled-content style=\"fixed-case\">IOP<\/jats:styled-content> in all mice tested. The antagonist, <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>\u20101918, blocked the effects of Abn\u2010<jats:styled-content style=\"fixed-case\">CBD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">NAG<\/jats:styled-content>ly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p>We present evidence for a functional <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18\u2010based signalling system in the murine anterior eye, including receptors and ligands. <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 agonists, Abn\u2010<jats:styled-content style=\"fixed-case\">CBD<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">NAG<\/jats:styled-content>ly, reduce <jats:styled-content style=\"fixed-case\">IOP<\/jats:styled-content> independently of <jats:styled-content style=\"fixed-case\">CB<jats:sub>1<\/jats:sub><\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">CB<jats:sub>2<\/jats:sub><\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>55. These findings suggest that <jats:styled-content style=\"fixed-case\">GPR<\/jats:styled-content>18 may serve as a desirable target for the development of novel ocular hypotensive medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Linked Articles<\/jats:title><jats:p>This article is part of a themed section on Cannabinoids. To view the other articles in this section visit <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1111\/bph.2013.169.issue-4\">http:\/\/dx.doi.org\/10.1111\/bph.2013.169.issue\u20104<\/jats:ext-link> &amp; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1111\/bph.2012.167.issue-8\">http:\/\/dx.doi.org\/10.1111\/bph.2012.167.issue\u20108<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.12136","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T03:55:14Z","timestamp":1362542114000},"page":"834-843","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["A <scp>GPR<\/scp>18\u2010based signalling system regulates <scp>IOP<\/scp> in murine eye"],"prefix":"10.1111","volume":"169","author":[{"given":"Meggie D.","family":"Caldwell","sequence":"first","affiliation":[{"name":"Department of Clinical Vision Science Dalhousie University  Halifax NS Canada"},{"name":"Department of Ophthalmology Dalhousie University  Halifax NS Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry Shu\u2010Jung","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Psychology National Cheng Kung University  Tainan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Department of Optometry Indiana University  Bloomington IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Bradshaw","sequence":"additional","affiliation":[{"name":"Department of Psychological &amp; Brain Sciences Indiana University  Bloomington IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie EM","family":"Kelly","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology Dalhousie University  Halifax NS Canada"},{"name":"Department of Pharmacology Dalhousie University  Halifax NS Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Straiker","sequence":"additional","affiliation":[{"name":"Department of Psychological &amp; Brain Sciences Indiana University  Bloomington IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,5,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1999.1410"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00933.2005"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2091-10-14"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/28393"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.102970"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.095"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000099240"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.161191698"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1470919"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1376"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03190100074024"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cne.22429"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107351200"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.185769"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707419"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00019.2008"},{"key":"e_1_2_8_18_1","first-page":"1577","article-title":"NC3Rs Reporting Guidelines Working Group","volume":"160","author":"Kilkenny C","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2006.06.175"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1237"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath J","journal-title":"Br J Pharmacol"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-44"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01497.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01497.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-7-10"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02854900"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0265"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708908200"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(98)00499-8"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.2174\/092986710790980050"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(98)00105-3"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.01027.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703050"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/42015"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00268.2002"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.25.14565"},{"key":"e_1_2_8_38_1","first-page":"2442","article-title":"Localization of cannabinoid CB1 receptors in the human anterior eye and retina","volume":"40","author":"Straiker AJ","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M413473200"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.003194"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12136","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T15:53:44Z","timestamp":1694447624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,27]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1111\/bph.12136"],"URL":"https:\/\/doi.org\/10.1111\/bph.12136","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,27]]},"assertion":[{"value":"2012-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-05-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}